Earnings History Data for vTv Therapeutics Inc. (VTVT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

vTv Therapeutics Inc.

vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company's drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-03-2023 AH VTVT vTv Therapeutics 83.00 -0.06 -0.06 0.00 0.8831 -0.06 
(-6.04%)		 0.88 -0.06 
(-6.39%)		 0.38 - 1.40 152,815 310,000 16,781
10-11-2022 AH VTVT vTv Therapeutics 105.00 -0.05 -0.05 0.00 vTv Therapeutics GAAP EPS of -$0.05
[11/10/2022 5:44 PM]		 0.8912 -0.03 
(-3.14%)		 0.85 -0.07 
(-7.62%)		 0.38 - 1.56 43,639 60,000 6,603
15-08-2022 PM VTVT vTv Therapeutics 113.00 -0.04 -0.10 0.00 vTv Therapeutics GAAP EPS of -$0.04
[8/16/2022 3:00 AM]		 1.21 -0.16 
(-11.68%)		 1.35 -0.02 
(-1.46%)		 0.38 - 2.17 597,615 420,000 31,678
12-05-2022 PM VTVT vTv Therapeutics Inc. 43.22 -0.10 -0.08 -0.09 vTv Therapeutics GAAP EPS of -$0.10, revenue of $2M
[5/12/2022 8:27 AM]		 0.4018 -0.02 
(-4.74%)		 0.42 0.0 
(-0.40%)		 0.39 - 2.88 740,219 190,000 960
09-11-2021 PM Before the open
(Nov 9)		 VTVT vTv Therapeutics 119.00 -0.02 -0.07 0.00 vTv Therapeutics EPS beats by $0.05, beats on revenue
[11/9/2021 9:00 AM]		 1.50 0.0 
(0.00%)		 1.43 -0.07 
(-4.67%)		 1.37 - 4.75 1,062,958 850,000 32,612
04-08-2021 AH 4:10 PM ET
(Aug 4)		 VTVT Vtv Therapeutics Inc. 157.00 -0.01 -0.07 0.00 vTv Therapeutics reports Q2 results
[8/4/2021 5:29 PM]		 1.91 -0.04 
(-2.30%)		 1.92 -0.04 
(-2.04%)		 1.44 - 4.75 396,205 320,000 1,361
05-05-2021 AH 4:30 PM ET
(May 5)		 VTVT Vtv Therapeutics Inc. 205.00 -0.09 -0.06 0.00 vTv Therapeutics EPS misses by $0.03, beats on revenue
[5/5/2021 5:08 PM]		 2.38 -0.05 
(-2.06%)		 2.40 -0.03 
(-1.23%)		 1.44 - 4.75 1,223,805 910,000 4,492
24-02-2021 AH VTVT Vtv Therapeutics Inc. 193.00 0.02 -0.06 0.00 vTv Therapeutics EPS beats by $0.08, beats on revenue
[2/24/2021 4:59 PM]		 2.54 0.02 
(0.59%)		 2.63 0.10 
(3.95%)		 1.44 - 4.75 1,116,952 2,751,726 76,819
24-02-2021 AH VTVT vTv Therapeutics Inc. 184.02 0.02 -0.05 -0.11 vTv Therapeutics EPS beats by $0.08, beats on revenue
[2/24/2021 4:59 PM]		 2.54 0.02 
(0.59%)		 2.63 0.10 
(3.95%)		 1.44 - 4.75 1,116,952 2,751,726 76,819